117 related articles for article (PubMed ID: 3332020)
1. Involvement of ras oncogenes in the initiation of carcinogen-induced tumors.
Barbacid M
Princess Takamatsu Symp; 1986; 17():43-53. PubMed ID: 3332020
[TBL] [Abstract][Full Text] [Related]
2. Absence of Ras mutations in rat DMBA-induced mammary tumors.
Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
[TBL] [Abstract][Full Text] [Related]
3. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
4. An experimental analysis of cancer: role of ras oncogenes in multistep carcinogenesis.
Sukumar S
Cancer Cells; 1990 Jul; 2(7):199-204. PubMed ID: 2204384
[TBL] [Abstract][Full Text] [Related]
5. Multistage carcinogenesis in murine thymocytes: involvement of oncogenes, chromosomal imbalances and T cell growth factor receptor.
Newcomb EW; Corominas M; Bayona W; Pellicer A
Anticancer Res; 1989; 9(5):1407-15. PubMed ID: 2686536
[TBL] [Abstract][Full Text] [Related]
6. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels.
Zhang R; Haag JD; Gould MN
Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653
[TBL] [Abstract][Full Text] [Related]
7. Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomas.
Garlick DS; Sukumar S; Barbacid M; Petit D; Hamer PJ; Leav I; Lavecchio JA; Trimpe KL; Carney WP
Hybridoma; 1991 Feb; 10(1):95-102. PubMed ID: 2032737
[TBL] [Abstract][Full Text] [Related]
8. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
[TBL] [Abstract][Full Text] [Related]
9. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis.
Quintanilla M; Brown K; Ramsden M; Balmain A
Nature; 1986 Jul 3-9; 322(6074):78-80. PubMed ID: 3014349
[TBL] [Abstract][Full Text] [Related]
10. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
11. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
[TBL] [Abstract][Full Text] [Related]
12. Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N-nitroso-N-methylurea.
Ariazi JL; Haag JD; Lindstrom MJ; Gould MN
Mol Carcinog; 2005 Jul; 43(3):155-64. PubMed ID: 15924352
[TBL] [Abstract][Full Text] [Related]
13. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
14. Agent-specific ras oncogene activation in rat thyroid tumours.
Lemoine NR; Mayall ES; Williams ED; Thurston V; Wynford-Thomas D
Oncogene; 1988 Nov; 3(5):541-4. PubMed ID: 3078959
[TBL] [Abstract][Full Text] [Related]
15. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.
Zarbl H; Sukumar S; Arthur AV; Martin-Zanca D; Barbacid M
Nature; 1985 May 30-Jun 5; 315(6018):382-5. PubMed ID: 3923365
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
17. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a] anthracene-induced rat leukemia.
Osaka M; Matsuo S; Koh T; Sugiyama T
Mol Carcinog; 1997 Apr; 18(4):206-12. PubMed ID: 9142215
[TBL] [Abstract][Full Text] [Related]
20. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
